These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12906022)

  • 1. Hepatitis B immunoglobulin: new preparation. Prolongs survival after liver transplantation.
    Prescrire Int; 2003 Aug; 12(66):135-7. PubMed ID: 12906022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins.
    Di Paolo D; Lenci I; Trinito MO; Carbone M; Longhi C; Tisone G; Angelico M
    Dig Liver Dis; 2006 Oct; 38(10):749-54. PubMed ID: 16916630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
    Jiao ZY; Jiao Z
    Transplant Proc; 2007 Jun; 39(5):1533-6. PubMed ID: 17580182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary transplant treatment of hepatitis B: hepatitis B immunoglobulin (passive immunization).
    Pruett T
    Liver Transpl Surg; 1997 Sep; 3(5 Suppl 1):S13-5. PubMed ID: 9377765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
    Takaki A; Yagi T; Iwasaki Y; Sadamori H; Matsukawa H; Matsuda H; Shinoura S; Umeda Y; Miyake Y; Terada R; Kobashi H; Sakaguchi K; Tanaka N; Shiratori Y
    Transplantation; 2007 Jan; 83(2):231-3. PubMed ID: 17264822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
    Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
    J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term follow-up of hepatitis B virus infected patients after orthotopic liver transplantation].
    Theilmann L; Arnold JC
    Z Gastroenterol; 1995 Oct; 33(10):626-7. PubMed ID: 7502560
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comprehensive prophylaxis and treatment of hepatitis B recurrence after liver transplantation].
    Shen ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):431-4. PubMed ID: 16178433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H
    Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uptake and elimination of hepatitis B immunoglobulin after intramuscular administration].
    Scheiermann N; Kuwert EK
    Dtsch Med Wochenschr; 1982 Dec; 107(50):1918-22. PubMed ID: 7140575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The questionable role of immunization against hepatitis B in HBV infected liver transplant patients.
    Samuel D; Shouval D
    J Hepatol; 2005 Aug; 43(2):203-6. PubMed ID: 15975686
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation in viral hepatitis: prevention of recurrence.
    Roche B; Samuel D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1153-69. PubMed ID: 19187873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine.
    Günther M; Neuhaus R; Bauer T; Jilg W; Holtz JA; Bienzle U
    Liver Transpl; 2006 Feb; 12(2):316-9. PubMed ID: 16447191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.
    Chan HL; Chui AK; Lau WY; Chan FK; Hui AY; Rao AR; Wong J; Lai EC; Sung JJ
    Clin Transplant; 2004 Jun; 18(3):295-300. PubMed ID: 15142051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.